Lupin completes acquisition of 42.61% stake in Sunsure Solarpark

10 Jan 2025 Evaluate

Lupin has completed the acquisition of 42.61% of the equity share capital of Sunsure Solarpark Seventeen (Sunsure Solarpark) and successfully completed the Transaction. The company has completed the acquisition on January 9, 2025. 

Earlier, the company had signed Share Subscription & Shareholders agreement with Sunsure Solarpark and Sunsure Energy (Sunsure) to make equity investment upto 42.61% of equity share capital of Sunsure Solarpark to be acquired at a total consideration not exceeding Rs 10.55 crore, to be completed in two tranches, in the capacity as a Captive User.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2137.15 -27.90 (-1.29%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×